Pegasys and PegIntron for the Treatment of HCV Pegasys + Ribavirin PegIntron + Ribavirin High dose peginterferon alfa-2b (PegIntron) Pegasys + Ribavirin Top Safety and Efficacy of Pegasys Plus Ribavirin in HCV Patients Intolerant or Nonresponsive to Treatment with PegIntron Plus Ribavirin - 11/23/05 Do Higher Doses of Anti-HCV Treatment Increase Responses?: A Tale of 3 Studies - 11/21/05 Fatigue Adversely Affects Virologic Response to Peginterferon Plus Ribavirin - 11/21/05 Is Shorter Treatment with Peginterferon Alfa-2a (Pegasys) Plus Ribavirin Possible in HCV Genotype 1 'Super Responders'? - 11/14/05 Retreatment with Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Patients Not Responding to Prior Peginterferon Alfa-2b (PegIntron)/ Ribavirin Combination Therapy-The REPEAT Study - 11/14/05 Efficacy of Peginterferon Alfa-2b (PegIntron) vs. Peginterferon Alfa-2a (Pegasys) Plus Ribavirin Regimens in Treatment-naïve Chronic HCV Patients: A Meta-analysis - 11/14/05 PegIntron + Ribavirin Top Safety and Efficacy of Pegasys Plus Ribavirin in HCV Patients Intolerant or Nonresponsive to Treatment with PegIntron Plus Ribavirin - 11/23/05 Does Psychiatric lllness Affect Compliance, Ability to Complete Treatment or the Response to Treatment with Peginterferon Plus Ribavirin? - 11/21/05 Fatigue Adversely Affects Virologic Response to Peginterferon Plus Ribavirin - 11/21/05 Does Weight-based Ribavirin Dosing Increase Sustained Viral Response in Patients with Chronic Hepatitis C? Final Results of the WIN-R Study - 11/18/05 Double-dose Peginterferon Alfa-2b (PegIntron) with Weight-based Ribavirin Improves the Response Rate for Nonresponders: The RENEW Trial - 11/16/05 Pegetron Prospective Optimal Weight-based Dosing Response Program (POWeR): Preliminary Results - 11/14/05 Retreatment with Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Patients Not Responding to Prior Peginterferon Alfa-2b (PegIntron)/ Ribavirin Combination Therapy-The REPEAT Study - 11/14/05 Efficacy of Peginterferon Alfa-2b (PegIntron) vs. Peginterferon Alfa-2a (Pegasys) Plus Ribavirin Regimens in Treatment-naïve Chronic HCV Patients: A Meta-analysis - 11/14/05 High dose peginterferon alfa-2b (PegIntron) Top Do Higher Doses of Anti-HCV Treatment Increase Responses?: A Tale of 3 Studies - 11/21/05
<--- Return to the 56th AASLD Main Page
